Supported by Pfizer
Chair(s)
Introduction
FIP is committed to transforming vaccination by accelerating vaccine equity, access and sustainability through life-course immunisation. It is critical to both recognize and understand the impact of pharmacy-based vaccination delivery on disease prevention throughout life’s ages and stages from childhood (including pregnancy) to late adulthood. This is key to supporting countries to develop policies that enable pharmacies and pharmacists to deliver integrated vaccination services throughout the life-course and as part of wider national immunisation policies.
Programme
12:45– 12:50 | Introduction by the chair | |
12:50 – 13:00 |
Transforming vaccination through a life-course approach to immunisation |
|
13:00 – 13:10 |
A shot at life starts early and lasts a lifetime |
|
13:10 – 13:20 |
The cumulative effect of vaccine inequities on older adults |
|
13:20 – 13:50 |
Panel discussion and Q&A: Identifying local issues of global relevance |
|
13:50 – 13:55 | Reflections Dr Catherine Duggan, FIP CEO |
|
13:55 – 14:00 | Conclusions by the chair and session close |
Learning Objectives
1. To describe life-course immunisation and the essential role of pharmacists in enabling it
2. To understand the impact of life course immunisation on different life ages and stages
3. To identify the importance of adopting a life-course approach to vaccination in pharmacy
4. To discuss how local needs for developing life-course immunisation differ across the globe